Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Melinda Weber"'
Autor:
Steven L. Halpern, David Panush, Elli G Paleoudis, Melinda Weber, Francis Patterson, Andrew Pecora, Jeffery Toretsky
Publikováno v:
Journal of Immunotherapy. 43:286-290
Epithelioid sarcoma, in the relapse-refractory setting, has limited expected survival. SMARCB1 inactivation, common in epithelioid sarcoma, causes loss of INI1 protein expression and overexpression of the cancer cell growth promoting methyltransferas
Autor:
Brittany A Sinclaire, Emily Tonti, Jaeil Ahn, Jordan Kaufman, Divya Cheruku, Adil Alaoui, Michael B. Atkins, Shaked lev-Ari, Andrew L. Pecora, Elli Gourna Paleoudis, Kanchi Krishnamurthy, Michael T Serzan, Andrew Ip, Eric Muller, Shari Adams, Sahil Parikh, Neil J. Shah, Shuo Wang, Aquino Williams, Melinda Weber
Publikováno v:
Journal of Clinical Oncology. 39:2635-2635
2635 Background: Immune Checkpoint Inhibitors (ICIs) are associated with unique immune-related adverse events (irAEs). IrAEs can occur at any timepoint of ICI treatment. Late irAEs are not well reported in the literature. Herein, we attempt to charac
Autor:
Brittany A Sinclaire, Shuo Wang, Michael T Serzan, Andrew Ip, Divya Cheruku, Emily Tonti, Neil J. Shah, Aquino Williams, Jordan Kaufman, Adil Alaoui, Elli Gourna Paleoudis, Jaeil Ahn, Sahil Parikh, Melinda Weber, Shari Adams, Michael B. Atkins, Andrew L. Pecora, Shaked lev-Ari, Eric Muller
Publikováno v:
Journal of Clinical Oncology. 39:2641-2641
2641 Background: Immune Checkpoint Inhibitors (ICI) have revolutionized current cancer treatment. Nevertheless, outcomes data across various patient cohorts are lacking. To address this knowledge gap, we conducted a comprehensive analysis of real-wor